Inflammatory bowel diseases (IBDs), particularly Crohn's disease (CD) and ulcerative colitis (UC), are associated with a variety of extra-intestinal manifestations (EIMs). About 36% of IBD patients have at least one EIM, which most frequently affect the joints, skin, eyes and the biliary tract. The EIMs associated with IBD have a negative impact on patients with UC and CD, and the resolution of most of them parallels that of the active IBD in terms of timing and required therapy; however, the clinical course of EIMs such as axial arthritis, pyoderma gangrenosum, uveitis, and primary sclerosing cholangitis is independent of IBD activity. The peripheral and axial arthritis associated with IBD have traditionally been treated with simple analgesics, non-steroidal anti-inflammatory drugs, steroids, sulfasalazine, methotrexate, local steroid injections and physiotherapy, but the introduction of biological response modifiers such as tumor necrosis factor-α blockers, has led to further improvements. © 2009 The WJG Press and Baishideng. All rights reserved.

Combined therapeutic approach : Inflammatory bowel diseases and peripheral or axial arthritis / F. Atzeni, S. Ardizzone, L. Bertani, M. Antivalle, A. Batticciotto, P. Sarzi Puttini. - In: WORLD JOURNAL OF GASTROENTEROLOGY. - ISSN 1007-9327. - 15:20(2009 May 28), pp. 2469-2471. [10.3748/wjg.15.2469]

Combined therapeutic approach : Inflammatory bowel diseases and peripheral or axial arthritis

S. Ardizzone
Secondo
;
L. Bertani
;
A. Batticciotto
Penultimo
;
P. Sarzi Puttini
Ultimo
2009

Abstract

Inflammatory bowel diseases (IBDs), particularly Crohn's disease (CD) and ulcerative colitis (UC), are associated with a variety of extra-intestinal manifestations (EIMs). About 36% of IBD patients have at least one EIM, which most frequently affect the joints, skin, eyes and the biliary tract. The EIMs associated with IBD have a negative impact on patients with UC and CD, and the resolution of most of them parallels that of the active IBD in terms of timing and required therapy; however, the clinical course of EIMs such as axial arthritis, pyoderma gangrenosum, uveitis, and primary sclerosing cholangitis is independent of IBD activity. The peripheral and axial arthritis associated with IBD have traditionally been treated with simple analgesics, non-steroidal anti-inflammatory drugs, steroids, sulfasalazine, methotrexate, local steroid injections and physiotherapy, but the introduction of biological response modifiers such as tumor necrosis factor-α blockers, has led to further improvements. © 2009 The WJG Press and Baishideng. All rights reserved.
anti-tumor necrosis factor antagonists; arthropathies; inflammatory bowel disease; treatment; gastroenterology
Settore MED/12 - Gastroenterologia
28-mag-2009
Article (author)
File in questo prodotto:
File Dimensione Formato  
Combined therapeutic approach.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 629.96 kB
Formato Adobe PDF
629.96 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/517451
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 19
social impact